Des-γ-carboxy prothrombin and α-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma

Cancer

Volumn 78, Issue 10, 1996, Pages 2094-2100

  Shimada, Mitsuo ^a   Takenaka, Kenji ^a   Fujiwara, Yuh ^a   Gion, Tomonobu ^a   Kajiyama, Kiyoshi ^a   Maeda, Takashi ^a   Shirabe, Ken ^a   Sugimachi, Keizo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

fetoprotein; Cox proportional hazards model; des carboxy prothrombin; hepatocellular carcinoma; prognostic indicator

Indexed keywords

ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CELL PROLIFERATION; EARLY DIAGNOSIS; HUMAN; IMMUNE RESPONSE; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTEIN PRECURSORS; PROTHROMBIN; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0029913526     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19961115)78:10<2094::AID-CNCR9>3.0.CO;2-O     Document Type: Article

References (19)

1. Matsumata T, Kanematsu T, Shirabe K, Sonoda T, Furuta T, Sugimachi K. Decreased morbidity and mortality rates in surgical patients with hepatocellular carcinoma Br J Surg 1990;77:677-80.
2. The Liver Cancer Study Group of Japan. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 1994;74:2772-80.
3. Shimada M, Matsumata T, Taketomi A, Yamamoto K, Itasaka H, Sugimachi K. Repeat hepatectomy for recurrent hepatocellular carcinoma. Surgery 1994;115:703-706.
4. Takenaka K, Yoshida K, Nishizaki T, Korenaga D, Hiroshige K, Ikeda T, et al. Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma. Am J Surg 1995;169:400-5.
5. Scudamore CH, Ragaz I, Kluftinger AM, Owen DA. Hepatocellular carcinoma: a comparison of oriental and Caucasian patients. Am J Surg 1988;155:659-62.
6. Sutton FM, Russell NC, Guinee VF, Alpert E. Factors affecting the prognosis of primary liver carcinoma. J Clin Oncol 1988;6:321-8.
7. Nomura F, Ohnishi K, Tanabe Y. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels: analysis of 606 patients. Cancer 1989;64:1700-6.
8. Fujiyama S, Morishita T, Sagara K, Sato T, Motohara K, Matsuda I. Clinical evaluation of plasma abnormal prothrombin (PIVKA II) in patients with hepatocellular carcinoma. Hepatogastroenterology 1986;33:201-5.
9. Fujiyama S, Morishita T, Hashiguchi O, Sato T. Plasma abnormal prothrombin (des-γ-carboxy prothrombin) as a marker of hepatocellular carcinoma. Cancer 1988;61:1621-8.
10. Nakao A, Suzuki Y, Isshiki K, Kimura Y, Takeda S, Kishimoto H, et al. Clinical evaluation of plasma abnormal prothrombin (des-γ-carboxy prothrombin) in hepatobiliary malignancies and other diseases. Am J Gastroenterol 1991;86:62-6.
11. Suehiro T, Matsumata T, Itasaka H, Taketomi A, Yamamoto K, Sugimachi K. Des-gamma-carboxy prothrombin and proliferative activity of hepatocellular carcinoma. Surgery 1995;117:682-91.
12. Sakon M, Monden M, Gotoh M, Kanai T, Umeshita K, Nakano Y, et al. Relationship between pathologic prognostic factors and abnormal levels of des-γ-carboxy prothrombin and α-fetoprotein in hepatocellular carcinoma. Am J Surg 1992;163:251-6.
13. Cox DR. Regression models and life tables. J R Stat Soc 1972;B34:187-220.
14. Mizejewski GJ. New insights into AFP structure and function: potential biomedical application. In: Mizejewski GJ, Porter IH, editors. Alpha-fetoprotein and congenital disorders. Orlando: Academic Press, 1985:5-34.
15. Murgita RA, Hooper DC, Stegagno M, Delovitch TL, Wigzell H. Characterization of murine inhibitory T lymphocytes: functional and phenotypic comparison with an adult T cell subset activated in vitro by alpha-fetoprotein. Eur J Immunol 1981;11:957-64.
16. Vogel CL, Primack A, Mclntire R, Carbone PP, Anthony PP. Serum alpha-fetoprotein in 184 Uganda patients with hepatocellular carcinoma: clinical, laboratory and histopathologic correlations. Cancer 1978; 33:959-64.
17. Carney DH, Herbosa GJ, Stiernberg J, Bergmann JS, Gordon BA, Scott D, et al. Double signal hypothesis for thrombin initiation of cell proliferation. Semin Thromb Hemost 1986;12:231-40.
18. Medrano EE, Cafferata EGA, Larcher F. Role of thrombin in the proliferative response of T-47D mammary tumor cells, Exp Cell Res 1987;172:354-64.
19. Inoue S, Nakao A, Harada A, Nonami T, Takagi H. Clinical significance of abnormal prothrombin (DCP) in relation to postoperative survival and prognosis in patients with hepatocellular carcinoma. Am J Gastroenterol 1994;89:2222-6.